Endocare's effectiveness has been scientifically proven in more than 20 years of clinical research. It has broad scientific support with several studies and numerous publications published in the main international medical journals. Evidence demonstrates an innovative and serious approach to treating skin aging.
This brand was developed from the Bioreparadora Technology of the Secretion of Cryptomphalus aspersa (SCA), a small land snail. This secretion, produced in response to environmental aggressions, has allowed it to survive over thousands of years. Extracted and purified according to pharmaceutical quality standards, it has a triple mechanism of action, which allows the regeneration of battered, aged and damaged skin:
Collagenase activity: Destruction of damaged skin collagen, allowing it to be replaced by new collagen, improving firmness and redefining the face contour.
Antioxidant activity: Protection against free radicals, responsible for premature skin aging.
Fibroblast stimulating activity: Facilitates skin regeneration, improving firmness, elasticity and hydration.
The regenerating power of each presentation of the Endocare line is determined by the secretion of Cryptomphalus aspersa (SCA), an index that varies between 2 and 50, and which quantifies the activation capacity of skin regeneration. To maximize the benefits of Endocare, the combined use of the entire line is recommended, so that the skin benefits from the cumulative effect of the Cryptomphalus aspersa (SCA) secretion of each product.
Cellage
This line provides an anti-wrinkle and nourishing action for the skin. With 3 new patented technologies: it allows skin renewal from the inside; acts on the effect of filling wrinkles and skin increase; and finally renews the epidermis acting on the origin of aging.
Tensage
This line firms and regenerates’ mature skin. Formulated with tensor peptides and swelling agents that promote collagen synthesis, improve skin firmness and elasticity, as well as the signs of skin photoaging.
